FDA, Conformia Meeting Breaks New Ground

Perhaps it wasn't all as "revolutionary" as this local Carolina press clip states , but clearly Conformia and FDA are doing some groundbreaking work that promises to change the status quo for drug development and manufacturing. We interviewed Conformia's cofounder Anjali Kataria and CDER Director Helen Winkle on the CRADA's progress recently and will provide an update next month.  The joint team also won one of our 2007 Teams of the Year awards for their work in bringing both industry and regulators to the table and opening up communication and dialogue within and between both groups. We'd like to hear more from FDA's other CRADA partners as well, and promise to pursue them. -AMS